Previous Page  15 / 25 Next Page
Information
Show Menu
Previous Page 15 / 25 Next Page
Page Background

Page 79

conferenceseries

.com

Volume 6, Issue 3 (Suppl)

J Neonatal Biol, an open access journal

ISSN:2167-0897

Neonatology 2017

December 04-06, 2017

December 04-06, 2017 | Madrid, Spain

20

th

International Conference on

NEONATOLOGY AND PERINATOLOGY

Congenital toxoplasmosis: Implementation of a surveillance system in France

Pr I Villena

University Reims Champagne-Ardenne, France

T

he national prevention programme for congenital toxoplasmosis in France has been in place since 1978; however, no data

is available concerning the annual number of cases. In order to estimate the perinatal burden of this infection, and to follow

the impact of the national prevention programme, a surveillance system was implemented in 2007 by the National Reference

Centre on Toxoplasmosis with support of Santé Publique France. We recommended a laboratory- based surveillance system as

being the most adapted for the surveillance of this infection. Several surveys were undertaken, in order to define the network of

contributors, and optimize the exhaustively of the surveillance. The surveillance system put in place, named ToxoSurv, is based

on a network of laboratories specialized in prenatal and postnatal diagnosis and medical biology laboratories that occasionally

perform a confirmatory diagnosis of this infection during the neonatal and postnatal periods. Cases are declared to the National

Reference Centre for Toxoplasmosis via the Internet or by the sending of a paper form. The data produced by this surveillance

will be used to produce an annual report destined for concerned health professionals. The surveillance system for congenital

toxoplasmosis has been active since June 2007 and provided valid prevalence data for congenital toxoplasmosis in France. The

number of congenital toxoplasmosis appears to be stable in France since 10 years with few cases of severe toxoplasmosis and

high proportion of subclinical forms. We also present French studies for treatment of congenital toxoplasmosis in antenatal

and neonatal period.

ivillena@chu-reims.fr

J Neonatal Biol 2017, 6:3(Suppl)

DOI: 10.4172/2167-0897-C1-006